-
1
First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis
Published 2024-12-01Subjects: Get full text
Article -
2
Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
Published 2024-10-01Subjects: Get full text
Article